BMKDF

Healthcare Diagnostics & Research

Biomark Diagnostics Inc.

$0.39

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

41.09M

Avg Volume

2,921

EPS

-$0.02

52W High

$0.50

52W Low

$0.22

Div. Yield

0.0%

Valuation

P/B Ratio

109.18

P/S Ratio

1477.78

EV/EBITDA

-23.83

EV/Revenue

1495.13

Margins

Gross Margin 100.0%

Operating Margin (5909.9%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(82.0%)

Return on Equity

(149.9%)

Return on Assets

(45.6%)

Liquidity & Leverage

Current Ratio

1.29

Quick Ratio

1.26

Debt / Equity

2.23

Total Cash

788,323

Total Debt

1.27M

About

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer and glioblastoma (GBM) breast cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.